Free Trial
→ Real Americans Don’t Wait on Wall Street’s Next Move (From Premier Gold Co) (Ad)
NASDAQ:BMRA

Biomerica 4/14/2025 Earnings Report

Biomerica logo
$0.48 +0.06 (+14.26%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$0.47 -0.01 (-2.71%)
As of 04/17/2025 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Earnings History

Biomerica EPS Results

Actual EPS
-$0.48
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Biomerica Revenue Results

Actual Revenue
$1.12 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Biomerica Announcement Details

Quarter
Date
4/14/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Biomerica Earnings Headlines

Biomerica Third Quarter 2025 Earnings: US$0.061 loss per share (vs US$0.11 loss in 3Q 2024)
April 18 at 11:02 PM | finance.yahoo.com
Biomerica Announced 1-for-8 Reverse Stock Split
April 18 at 6:01 PM | nasdaq.com
Real Americans Don’t Wait on Wall Street’s Next Move
What's happening in the markets right now should concern every freedom-loving American who's worked hard and saved smart. Your 401(k) doesn't deserve to be dragged through the mud by tariffs, trade wars, reckless spending, and political standoffs. And you don't have to stand by while Wall Street plays roulette with your future.
April 19, 2025 | Premier Gold Co (Ad)
Biomerica, Inc.: Biomerica Announces Reverse Stock Split
April 18 at 5:35 AM | finanznachrichten.de
Biomerica Inc trading halted, news pending
April 18 at 5:35 AM | markets.businessinsider.com
Biomerica says UAE Ministry of Health approves Fortel Kidney Disease Test
April 18 at 12:34 AM | markets.businessinsider.com
See More Biomerica Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biomerica? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biomerica and other key companies, straight to your email.

About Biomerica

Biomerica (NASDAQ:BMRA), a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

View Biomerica Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles